NCT00654992View on ClinicalTrials.gov

Effect of Erythropoietin (EPO) in Kidney After Cardiac Surgery

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

71

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

February 29, 2008

Study Completion Date

February 28, 2009

Conditions
Kidney Failure, Acute
Interventions
DRUG

Erythropoietin-Beta

300 IU/kg of EPO or saline intravenously before surgery

DRUG

Normal Saline

300 IU/kg of normal saline intravenously before surgery

Trial Locations (1)

463-707

Seoul National University Bundang Hospital, Seongnam-si

All Listed Sponsors
lead

Seoul National University Bundang Hospital

OTHER

NCT00654992 - Effect of Erythropoietin (EPO) in Kidney After Cardiac Surgery | Biotech Hunter | Biotech Hunter